Martina Ferrara

ORCID: 0000-0002-9217-7027 · 3 papers in corpus
observational 2023
Healthcare (Basel, Switzerland) ·doi:10.3390/healthcare11131922

Borderline ovarian tumors (BOTs) comprise 15-20% of primary ovarian neoplasms and represent an independent disease entity among epithelial ovarian cancers. The present study (Clinical Trial ID: NCT05791838) aimed to report a retrospective a…

other 2022
Frontiers in medicine ·doi:10.3389/fmed.2022.1018232

BACKGROUND: The aim of this study is to evaluate the initial feasibility, safety, and outcomes of hysterectomy performed by transvaginal natural orifice transluminal endoscopic surgery (vNOTES) at three institutions in Italy. MATERIALS AND…

observational 2022
Medicina (Kaunas, Lithuania) ·doi:10.3390/medicina58121706

Background and Objectives: We aimed to evaluate Progression Free Survival (PFS), Overall Survival (OS), and relapse rate in women affected by endometrioid ovarian cancer and synchronous endometrial-ovarian endometrioid cancer (SEO-EC). As s…